Building access to the Regenstrief Institute is restricted at least through July 5, 2020. More on our coronavirus precautions.
See our coronavirus precautions.

Imperiale named IU’s first Lawrence Lumeng Professor in Gastroenterology and Hepatology

INDIANAPOLIS — Regenstrief Institute investigator Thomas F. Imperiale, M.D., has been named the inaugural Lawrence Lumeng Professor in Gastroenterology and Hepatology at Indiana University School of Medicine. Dr. Imperiale is an internationally respected health services researcher and a clinical gastroenterologist.

Dr. Imperiale’s research, which has been funded by the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Department of Veterans Affairs and other organizations, focuses on developing and testing screening strategies for colorectal cancer based on risk factors. His findings have been published in highly regarded journals including the New England Journal of Medicine, Journal of the American Medical Association, Annals of Internal Medicine and Gastroenterology.

In addition to the IU School of Medicine, Dr. Imperiale holds appointments with the Regenstrief Institute’s William M. Tierney Center for Health Services Research, the IU Center for Health Services and Outcomes Research, the VA Center for Health Information and the Indiana University Melvin and Bren Simon Cancer Center.

The new endowed professorship is named for Lawrence Lumeng, M.D., who was the Division Director of imperiale-t01-5x7-jpgGastroenterology and Hepatology in the Department of Medicine at the IU School of Medicine from 1983 to 2007. Under Dr. Lumeng’s leadership, the division pursued excellence in patient care and innovation in research and education.

“Dr. Lumeng hired me twenty years ago and I joke that he knew what I was going to do — outcomes research — before I knew it,” said Dr. Imperiale. “Screening for colorectal cancer saves lives. I am working to apply knowledge and technology to tailor colorectal cancer screening to an individual’s specific risk factors so that we can offer choices that are appropriate to that risk making screening more personalized, efficient, and in many cases, permissive and flexible.”

Dr. Imperiale is a graduate of City University of New York, earned his medical degree at New York University, was a resident in internal medicine at Case Western Reserve University and completed fellowships in clinical epidemiology at Yale University and in gastroenterology at Case Western Reserve University. Since joining IU in 1996 and the Regenstrief Institute in 2000 he has mentored more than thirty medical residents, fellows and junior faculty members. He is a recipient of the Regenstrief Institute’s Outstanding Investigator Award and the IU Trustee Teaching Award.

Related News

Jun 01, 2020 • News
International audience attending conference on AI in healthcare
Starting today, June 1, at 11 a.m., more than 430 people from 16 countries are participating in a virtual conference focused on applying artificial intelligence (AI) for healthcare hosted by Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI). Over the course of three days, “Artificial Intelligence: Applying Research and Engineering Solutions for Emergent…
Continue Reading >
May 28, 2020 • News
Partnerships between State and Regenstrief strengthen COVID-19 response
As cases of COVID-19 spread throughout Indiana, state leaders have been working closely with Regenstrief Institute in the efforts to contain the outbreak. Partnerships have provided data and analysis to inform statewide policies as well as strengthen preparedness in Hoosier nursing homes. Sharing data Through a data-sharing collaboration, Regenstrief led the development of a COVID-19…
Continue Reading >